Cargando…

Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a highly malignant tumor. In this study, we sought to identify a novel biomarker for HCC by analyzing transcriptome and clinical data. The R software was used to analyze the differentially expressed genes (DEGs) in the datasets GSE74656 and GSE84598 downloaded from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Qiuli, Tan, Chao, Xiao, Feifei, Yin, Fuqiang, Liu, Meiliang, Lei, Lei, Wu, Liuyu, Yang, Yu, Tan, Hui Juan Jennifer, Liu, Shun, Zeng, Xiaoyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554696/ https://www.ncbi.nlm.nih.gov/pubmed/33974527 http://dx.doi.org/10.17305/bjbms.2021.5690

Ejemplares similares

Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer
por: Liu, Meiliang, et al.
Publicado: (2020)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer
por: Li, Chanyuan, et al.
Publicado: (2023)

ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancer
por: Gu, Wenchao, et al.
Publicado: (2022)

Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma
por: Xie, Haixiang, et al.
Publicado: (2023)

Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma
por: Mo, Meile, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients
por: Palumbo, Valeria, et al.
Publicado: (2009)

Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo
por: Ma, Xiaoyun, et al.
Publicado: (2022)

ITGB4 is a novel prognostic factor in colon cancer
por: Li, Meng, et al.
Publicado: (2019)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
por: Wu, Pancheng, et al.
Publicado: (2019)

Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer
por: Wang, Xiao-Min, et al.
Publicado: (2013)

ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion
por: Ahmad, Salma M S, et al.
Publicado: (2023)

Polymorphisms in MicroRNA Target Sites of Forkhead Box O Genes Are Associated with Hepatocellular Carcinoma
por: Tan, Chao, et al.
Publicado: (2015)

Single-Exosome Profiling Identifies ITGB3+ and ITGAM+ Exosome Subpopulations as Promising Early Diagnostic Biomarkers and Therapeutic Targets for Colorectal Cancer
por: Guo, Wei, et al.
Publicado: (2023)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma
por: Damanakis, Alexander I., et al.
Publicado: (2022)

MicroRNA-3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1
por: Zhang, Lijuan, et al.
Publicado: (2019)

ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer
por: Jiang, Xia, et al.
Publicado: (2021)

The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung Cancer
por: Zu, Lingling, et al.
Publicado: (2022)

ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT Pathways
por: Xie, Jinghe, et al.
Publicado: (2021)

LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2
por: Liu, Mengyao, et al.
Publicado: (2018)

eRF3b, a Biomarker for Hepatocellular Carcinoma, Influences Cell Cycle and Phosphoralation Status of 4E-BP1
por: Li, Man, et al.
Publicado: (2014)

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
por: Zhu, Tingting, et al.
Publicado: (2020)

Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021)

Insufficient Radiofrequency Ablation Treated Hepatocellular Carcinoma Cells Promote Metastasis by Up-Regulation ITGB3
por: Zhang, Ning, et al.
Publicado: (2017)

ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma
por: Shi, Ying, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Fan, Yumei, et al.
Publicado: (2021)

A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients
por: Bai, Wen Dong, et al.
Publicado: (2022)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG)
por: Liu, He, et al.
Publicado: (2023)

MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3
por: Sun, Lijuan, et al.
Publicado: (2015)

Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Yan, Yan, et al.
Publicado: (2022)

Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients
por: Zeng, Jun, et al.
Publicado: (2015)

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Zhou, Lei, et al.
Publicado: (2022)

Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhang, Feng, et al.
Publicado: (2021)

EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma
por: Guo, Baoping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q2qfatbfq6dqbkg7usiegjjdl4